# Comparison of Short Versus 12 Months Prasugrel Plus Aspirin in Patients with Acute Coronary Syndromes Treated with Percutaneous Coronary Intervention and Everolimus-eluting Stents

> **NCT06718179** · PHASE4 · RECRUITING · sponsor: **Odense University Hospital** · enrollment: 3150 (estimated)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DRUG:** Short duration of aspirin and prasugrel
- **DRUG:** Conventional duration of aspirin and prasugrel

## Key facts

- **NCT ID:** NCT06718179
- **Lead sponsor:** Odense University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-16
- **Primary completion:** 2029-11
- **Final completion:** 2030-12
- **Target enrollment:** 3150 (ESTIMATED)
- **Last updated:** 2025-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06718179

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06718179, "Comparison of Short Versus 12 Months Prasugrel Plus Aspirin in Patients with Acute Coronary Syndromes Treated with Percutaneous Coronary Intervention and Everolimus-eluting Stents". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06718179. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*